Person time at risk of malaria was calculated from the date of a given dose of IPTi until a subsequent dose was administered, malaria was diagnosed, or the individual exited the study (dropped out, migrated or died), whichever occurred first.
Although HEWs administer anti-malaria drugs, several participants complained that they were not given the drugs.
In the first clinical trial of an AMA1 vaccine in an endemic area, the AMA1-C1 vaccine was safe when administered to malaria-exposed adults and, at the highest dose, was able to induce significant immune responses against the individual vaccine components as well as against a heterologous AMA1 allele.
CHWs in iCCM model A clusters were taught to perform and interpret RDTs for malaria, administer artemether-lumefantrine (AL) to children who tested positive for malaria, and administer amoxicillin for treatment of children diagnosed with non-severe pneumonia.
Another option is a community based, volunteer delivery systems of the kind that has been used successfully for mass treatment of onchocerciasis [6], lymphatic filariasis [7], schistosomiasis [8], and trachoma and to administer treatment for malaria [9], [10], [11], [12].
Villagers with no previous medical training were trained to recognize the symptoms of severe malaria, administer rectal artesunate and refer patients to hospital.
Artemisinins, discovered by Chinese scientist Tu Youyou and colleagues in the 1970s from the plant Artemisia annua, became the recommended treatment for P. falciparum malaria, administered in combination with other antimalarials as well as in severe disease.
To examine the medicines and dosage that mothers who engage in home-based malaria management administer to children aged ≤ 5 years having signs and symptoms associated with malaria and to discuss the possibilities of designing an effective home-based malaria management strategy.
The factor was not generated in mice administered dieldrin and infected with malaria nor in mice administered only dieldrin nor in mice only infected with Leishmania.
Three doses of each formulation were administered intramuscularly by needle-less jet injection at 0, 4 and 8 weeks, and each cohort had controlled human malaria infection administered by five mosquito bites 18 d later.
